The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE SignalingKaren T. Liby, Michael B. Sporn|Cancer Research|2005Cited by 283
The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer CellsKaren T. Liby, John J. Letterio|Clinical Cancer Research|2006Cited by 118
A Novel Acetylenic Tricyclic <i>bis</i>-(Cyano Enone) Potently Induces Phase 2 Cytoprotective Pathways and Blocks Liver Carcinogenesis Induced by AflatoxinKaren T. Liby, Michael B. Sporn|Cancer Research|2008Cited by 51
A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to ChemotherapyDi Zhang, Karen T. Liby|Molecular Cancer Therapeutics|2021Cited by 44
Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient miceDi Zhang, Karen T. Liby|Scientific Reports|2021Cited by 11